Results 121 to 130 of about 38,466 (239)

Ophthalmic Vascular Occlusion and Blindness After Platelet‐Rich Plasma Injections: A Systematic Review

open access: yesJournal of Cosmetic Dermatology, Volume 25, Issue 6, June 2026.
ABSTRACT Background Platelet‐rich plasma (PRP) is widely used in aesthetic and regenerative medicine; however, rare vision‐threatening complications such as blindness have been reported following facial injections. Aims This systematic review aimed to identify and analyze all published cases of visual impairment following PRP injections.
Mandana Ebrahimzade   +6 more
wiley   +1 more source

Is Thrombolytic Therapy Safe When Used to Treat Elderly Patients?

open access: yes, 2011
Recently, research has been conducted to determine if thrombolytic therapy works to dissolve clots and if it is a safe treatment option. The specific purpose of this study is to determine if thrombolytic therapy is safe for use in the elderly. This study
Yaeger, Daniel
core  

Protocoled thrombolytic therapy for frostbite improves phalangeal salvage rates.

open access: yes, 2020
Background: Frostbite is a cold injury that has the potential to cause considerable morbidity and long-term disability. Despite the complexity of these patients, diagnostic and treatment practices lack standardization. Thrombolytic therapy has emerged as
Kloda, Daniel   +5 more
core  

Incidence of Neurological Syndromes After Thrombolytic Therapy In Elderly Patients With Acute Myocardial Infarction

open access: yesمجله دانشکده پزشکی اصفهان, 2008
Background: Reperfusion therapy is the standard treatment of acute myocardial infarction (AMI). If the percutaneous coronary intervention (PCI), as a preferred reperfusion strategy, was not available, thrombolytic therapy is chosen as an alternative ...
Hassan Shemirani   +1 more
doaj  

Thrombolytic therapy [PDF]

open access: yesCanadian Anaesthetists’ Society Journal, 1985
A, Bailey, J C, Lydon, F J, Spielman
openaire   +2 more sources

Thrombolytic therapy for acute coronary obstruction: status in 1986 [PDF]

open access: yes, 1986
The effect of thrombolysis in acute myocardial infarction on enzymatic infarct size, left ventricular function, and early mortality was studied in subsets of patients in a randomized trial at The Netherlands Interuniversity Cardiological Institute during
Hugenholtz, P.G. (Paul)   +3 more
core  

Update on Thrombolytic Therapy in Acute Pulmonary Thromboembolism

open access: yes, 2019
Thrombolytic treatment accelerates the dissolution of thrombus in acute pulmonary thromboembolism (PTE) and is potentially a lifesaving treatment. High-risk PTE is the clearest indication for this therapy, and its use in intermediate-risk cases is still ...
YILMAZEL UÇAR, Elif, Elif Yilmazel Ucar
core   +1 more source

Non-administration of thrombolytic agents in acute myocardial infarction patients in Hajar hospital, Shahrekord, Iran: prevalence rate and causes

open access: yesARYA Atherosclerosis, 2013
BACKGROUND: Cardiovascular diseases are the major causes of mortality worldwide and acute myocardial infarction (AMI) is the leading cause of mortality among cardiovascular diseases. Thrombolytic therapies, especially during the first few hours after the
Mohammadreza Samieinasab   +4 more
doaj  

Feasibility of acute thrombolytic therapy for stroke

open access: yes, 2003
Background: Thrombolysis is an expensive medical intervention for ischemic stroke and hence there is a need to study the feasibility of thrombolysis in rural India. Aims: To asses the feasibility and limitations of providing thrombolytic therapy to acute
K. Nandigam   +5 more
core   +1 more source

Recent advances in intra-arterial thrombolysis

open access: yesAnnals of Indian Academy of Neurology, 2008
Thrombolytic therapy has revolutionized acute ischemic stroke (AIS) treatment; however it is clear that intravenous (IV) thrombolytic therapy has certain limitations, including a short-time window for use, poor specificity for the site of arterial ...
Bershad Eric, Suarez Jose
doaj  

Home - About - Disclaimer - Privacy